Enter your drug, your current dose and the date you started it. This tells you where you sit on the approved ladder, how long you have been there, and the earliest date the label allows a change. It remembers, so next week you just open it.
Every approved GLP-1 ladder is built on a minimum of four weeks at each dose before moving up. That interval is not a target to hit — it is a floor. It exists because the gastrointestinal side effects track the rate of increase more than the dose itself, and because the trials that produced the efficacy numbers used that schedule.
So this tool tells you the earliest date the label permits a change. It does not tell you to make one. Plenty of people stay at a mid-ladder dose for months because it is working and tolerable, and plenty stay because moving up made them miserable. Both are normal, and both are decisions for whoever writes your prescription.
| Drug | Steps, weekly |
|---|---|
| Wegovy | 0.25 → 0.5 → 1 → 1.7 → 2.4 mg (a 7.2 mg high-dose option was added in 2026) |
| Ozempic | 0.25 → 0.5 → 1 → 2 mg — indicated for type 2 diabetes |
| Zepbound / Mounjaro | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg |
If you were on a compounded product and your dose does not appear on any of these ladders, that is the situation the switching page covers — there is no clean mapping, and the number is not yours to pick.
Where your weight should be by this week · Whether your stall is actually a stall · What tends to happen after a step up · Your protein target at this weight
Information, not medical advice. This is a calendar, not a prescriber. It does not recommend a dose, a change, or a timing, and it cannot see your history or how you are tolerating treatment. Never change a dose, skip one, or double one without the person who prescribed it. If you have missed a dose, check your product's label instructions or call your prescriber rather than guessing.
Trial-average pounds, month by month: Zepbound · Wegovy · Ozempic · every weight from 180 to 400 lbs
Protein, fibre, electrolytes and one way to measure. The same short list solves most of what goes wrong early.
See the starter kit →One short email a week: the trial-average number for the week you are on, what counts as a normal stall, and what does not.
No spam. Unsubscribe any time. Educational information only, not medical advice.